Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5854)
All Articles published online
|
Publishing Process of This Article
|
Jun 27, 2025 (publication date) through May 4, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Pandey H, Goel P, Srinivasan VM, Tang DWT, Wong SH, Lal D. Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics. World J Hepatol 2025; 17(6): 106849 [PMID: 40606926 DOI: 10.4254/wjh.v17.i6.106849] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Pandey H, Goel P, Srinivasan VM, Tang DWT, Wong SH, Lal D. Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics. World J Hepatol 2025; 17(6): 106849 [PMID: 40606926 DOI: 10.4254/wjh.v17.i6.106849] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i6/106849.htm |
| Number | Citing Articles |
| 1 |
Muhammad Y. Sheikh, Muhammad F. Younus, Annie Shergill, Muhammad N. Hasan. Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 2025; 26(19): 9625 doi: 10.3390/ijms26199625
|
| 2 |
Zuzanna Szkamruk, Joanna Cielecka, Maciej Walędziak, Anna Różańska-Walędziak. The Role of Gut Microbiota in Type 2 Diabetes: From Dysbiosis to Therapeutic Opportunities—A literature review. Bratislava Medical Journal 2026; doi: 10.1007/s44411-026-00596-0
|
| 3 |
Jiali Wu, Xuenan Liu, Yangpeng Li, Jing Liu, Biao Jia, Hongye Peng, Qin Yuan, Wen Liu, Shengpeng Wang, Duosheng Luo, Xianglu Rong, Wenliang Lv, Jiao Guo. Atractylodes Macrocephala Polysaccharides Ameliorate Diabetic Hepatorenal Injury and Remodel Gut Microbiota in Mice. Food Science & Nutrition 2026; 14(4) doi: 10.1002/fsn3.71700
|
| 4 |
Katarzyna Pacyga, Aleksandra Tabiś, Paweł Pacyga. Medicinal Plants for a Healthy Gut Microbiome: Scientific Insights into Modern Herbal Applications. International Journal of Molecular Sciences 2025; 26(22): 10875 doi: 10.3390/ijms262210875
|
| 5 |
Yanhao Qiu, Juan Carlos Laguna, Marta Alegret, Laia Vilà. A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation. Nutrients 2026; 18(4): 679 doi: 10.3390/nu18040679
|
| 6 |
Priyankar Dey. Gut microbial signatures associated with the Indian lean MASLD phenotype. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1673517
|
| 7 |
Supriyo Ghosh, Amlan Jyoti Ghosh, Manab Deb Adhikari, Bipransh Kumar Tiwary, Tilak Saha. Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights. Journal of Diabetes & Metabolic Disorders 2026; 25(1) doi: 10.1007/s40200-026-01861-3
|
| 8 |
Bratati Bandyopadhyay, Souparna Sasmal, Ayantika Kanrar, Shreya Adhikary. Reactive Oxygen Species in Metabolic Inflammation. 2026; : 157 doi: 10.1007/978-3-032-11752-6_8
|
| 9 |
Pablo Méndez-Albiñana, Laia Cros-Brunsó, Raquel Rodrigues-Díez, Pilar Rodríguez-Rodríguez, Luis Santamaría, Ana Muñoz-Labrador, Teresa Requena, Laura Casani, Francisco Félix Caballero, Ma Isabel Prieto-Nieto, Mar Villamiel, Javier Blanco-Rivero. Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: role of perivascular mesenteric innervation. Bioactive Carbohydrates and Dietary Fibre 2025; 34: 100505 doi: 10.1016/j.bcdf.2025.100505
|
| 10 |
Chunmei Ran, Xiaoyan Gao, Yongqin Zhou, Chibing Dai. Critical role of interleukin-33 in pathogenesis and progression of metabolic dysfunction-associated steatotic liver disease. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1762478
|